Cramer Says Pfizer (PFE) Should Buy Allergan (AGN)
On Mad Money tonight, Jim Cramer said Pfizer (NYSE: PFE) should really take a strong look at buying Allergan (NYSE: AGN). Cramer thinks this is a smart play similar to Johnson & Johnson buying out Mentor Corporation (NYSE: MNT) earlier in the week.
Both Allergan and Mentor produce products that are used in cosmetic surgeries.
Additionally, Cramer liked that Allergan has a strong growth rate, whereas Pfizer has no growth. Therefore, if Pfizer makes a play for Allergan, it would get that much needed growth the Street covets.
In today's trading, Allergan closed at $36.20 and currently in the after-hours it is at $35.18.
Allergan, Inc. is a multi-specialty healthcare company focused on developing and commercializing pharmaceuticals, biologics and medical devices.
Sign up at EasyStockAlerts.com To Be Alerted To Your Stock News!
Create E-mail AlertRelated Categories
Insiders' BlogTrader Talk
Stocks Mentioned
-1.27
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
